Zymfentra (infliximab-dyyb subcutaneous) - Celltrion
infliximab oral (TH023) - Celltrion, Tharimmune, Intract Pharma
Humira (adalimumab) - AbbVie
Humira SC (adalimumab/hyaluronidase) - AbbVie
Steqeyma (ustekinumab-stba) - Celltrion, Hikma
Stelara (ustekinumab) - J&J
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Rinvoq (upadacitinib) - AbbVie
Yuflyma (adalimumab-aaty) - Celltrion, Hikma
Entyvio SC (vedolizumab SC) - Takeda
http://www.ncbi.nlm.nih.gov/pubmed/41553714
 
Dong-Hyeon Kim; Hyunsoo Park; Jean-Frederic Colombel; Peter M Irving; Silvio Danese; Stefan Schreiber; Stephen B Hanauer; Tadakazu Hisamatsu; Young Nam Lee
 
Jan 19, 2026
 
Next